Nephs: CKD in T2D Treatment | CKD in T2D Amplifies CV Risk
SponsoredView A Cardiorenal Therapy For CKD in T2D That Delays CKD Progression In Pati…Patient Profiles · FDA-Approved Treatment · Mechanism of Action · Prescribing Information
HCPs: Burdens Of IgAN | View Kidney Failure Risks
SponsoredHCPs: Understand The Symptoms And Risks That IgA Nephropathy Can Produce. …

Feedback